Fecal miR‐223 is a noninvasive biomarker for estimating Crohn's disease activity
Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, Qiurong Li · 2023
Read Fecal miR‐223 is a noninvasive biomarker for estimating Crohn's disease activity by Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, Qiurong Li (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10753866.txt.
Description
Juanjuan Zhang and four co-authors test a stool mark for Crohn's flare in a 2023 study. A small RNA named miR-223 had looked strong as a no-cut sign of the gut ill, but which source, blood, gut wall, or stool, read flare best was not known.
The team took all three from patients and sound peers. Scores for flare, spread kind, drugs, and blood marks were logged beside each read. The RNA ran high in patients in all three sources. Stool, the easiest to take, is weighed as the flare gauge. A home-grown test may one day spare scopes.
Catalog record
| CREATOR | Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, Qiurong Li |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |